Clinical Trial Update: Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

The document reports a Phase 1/Phase 2 clinical trial evaluating MRI perfusion as a method to detect disease in prostate cancer, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University Health Network, Toronto | Conditions: Prostatic Neoplasms | Phase 1, Phase 2 | Status: COMPLETED